|
 |
| home > pmps > spring 2003 > maximising the benefits of brand security - new developments for smart protection |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Much has been said about the escalating problem and staggering numbers related to counterfeiting in the pharmaceutical industry, to the point where no large manufacturer can avoid taking a pro-active approach and initiating a product security programme. In order for a programme to be effective however, it should include some form of product marking technology, whether applied to the primary packaging, secondary packaging, labels or to all of the above.
When considering such technologies, a cost/benefit analysis will typically include an evaluation of the overall technology attributes, its applicability to specific challenges and the environment in which it is implemented. Some of the issues that need to be addressed are: the type of problem (counterfeiting, repackaging, diverting); mapping of geographical areas and distribution channels involved; suspected origins of fake drugs; existing levels of control over the supply chain; the type and amount of information that requires validation; and nature of inspection (in the field versus back office).
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLineŽ ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLineŽ ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLineŽ is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
